Phosphatidic Acid Stimulates Myoblast Proliferation through Interaction with LPA1 and LPA2 Receptors

• Published in: International journal of molecular sciences 2021-02, Vol.22 (3), p.1452
• Main Authors: Gomez-Larrauri, Ana, Gangoiti, Patricia, Presa, Natalia, Dominguez-Herrera, Asier, Donati, Chiara, Bruni, Paola, Trueba, Miguel, Gomez-Muñoz, Antonio, Ouro, Alberto
• Format: Article
• Language: English
• Subjects: 1-Phosphatidylinositol 3-kinase; AKT protein; Cell cycle; Cell differentiation; Cell division; Cell growth; Chemotaxis; Deoxyribonucleic acid; DNA; Extracellular signal-regulated kinase; Gene silencing; Genes; Kinases; Leukocytes (neutrophilic); lysophosphatidic acid; lysophosphatidic acid receptors; Musculoskeletal system; myoblast proliferation; Myoblasts; Pertussis; Pertussis toxin; Pharmacology; Phosphatidic acid; Phospholipids; Phosphorylation; Pretreatment; Proteins; Silence; siRNA; Thymidine
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms22031452

Phosphatidic acid (PA) is a bioactive phospholipid capable of regulating key biological functions, including neutrophil respiratory burst, chemotaxis, or cell growth and differentiation. However, the mechanisms whereby PA exerts these actions are not completely understood. In this work, we show that PA stimulates myoblast proliferation, as determined by measuring the incorporation of [ H]thymidine into DNA and by staining the cells with crystal violet. PA induced the rapid phosphorylation of Akt and ERK1/2, and pretreatment of the cells with specific small interferin RNA (siRNA) to silence the genes encoding these kinases, or with selective pharmacologic inhibitors, blocked PA-stimulated myoblast proliferation. The mitogenic effects of PA were abolished by the preincubation of the myoblasts with pertussis toxin, a Gi protein inhibitor, suggesting the implication of Gi protein-coupled receptors in this action. Although some of the effects of PA have been associated with its possible conversion to lysoPA (LPA), treatment of the myoblasts with PA for up to 60 min did not produce any significant amount of LPA in these cells. Of interest, pharmacological blockade of the LPA receptors 1 and 2, or specific siRNA to silence the genes encoding these receptors, abolished PA-stimulated myoblast proliferation. Moreover, PA was able to compete with LPA for binding to LPA receptors, suggesting that PA can act as a ligand of LPA receptors. It can be concluded that PA stimulates myoblast proliferation through interaction with LPA1 and LPA2 receptors and the subsequent activation of the PI3K/Akt and MEK/ERK1-2 pathways, independently of LPA formation.